Swedish Cancer Institute Taking Part in Development of Cell-CT™ Platform for Lung Cancer Risk Assessment

Swedish Cancer Institute Taking Part in Clinical Trial of Sputum Test for Early Detection of Lung Cancer SEATTLE, May, 2, 2008 – Swedish Cancer Institute announced today it is collaborating with VisionGate, Inc. – a privately held biomed/biotech company based in Seattle – to provide samples from lung-cancer patients for further development of VisionGate’s Cell-CT […]

more May 1 2008


This is my first post!

more No Comments May 31 1999

Copyright 2019 - VisionGate, Inc.